Roberts Glore & Co »

Adma Biologics shares owned by Roberts Glore & Co

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Roberts Glore & Co from 13F filings

Historical chart of Roberts Glore & Co investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Roberts Glore & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Roberts Glore & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $377k 26k 14.66

More positions owned by Roberts Glore & Co

Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Johnson & Johnson (JNJ)
Vanguard Index Fds Total Stk Mkt (VTI)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Abbott Laboratories (ABT)
Abbvie (ABBV)
Amazon (AMZN)
Stryker Corporation (SYK)
Sprott Asset Management Physical Gold An (CEF)
NVIDIA Corporation (NVDA)

View all positions for Roberts Glore & Co

Top funds holding Adma Biologics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Sachem Head Capital Management
Geode Capital Management
Nuveen
Westfield Capital Management Company
Dimensional Fund Advisors
American Century Companies
Thrivent Financial for Lutherans
Citadel Advisors
Capital Research Global Investors
Goldman Sachs Group
Franklin Resources

View all funds holding Adma Biologics